BackBelite Bio Overview

Belite Bio Selling, General & Admin

See how BLTE's SG&A expenses trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$17.02M
178.11% YoY

As of Mar 31, 2026

Annual SG&A Expenses (TTM)

$49.73M
236.37% YoY

Trailing 12 months ending Mar 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Belite Bio (BLTE) FAQ

Stockcircle tracks selling, general & admin for Belite Bio (BLTE), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for Belite Bio's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main BLTE overview so you can move from this figure to the surrounding analysis quickly.